SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001286
Filing Date
2024-01-12
Accepted
2024-01-12 16:30:39
Documents
14
Period of Report
2024-01-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20240109_8k.htm   iXBRL 8-K 27150
2 EXHIBIT 16.1 ex_613823.htm EX-16.1 3222
  Complete submission text file 0001437749-24-001286.txt   152170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arch-20240109.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20240109_def.xml EX-101.DEF 10353
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20240109_lab.xml EX-101.LAB 13836
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20240109_pre.xml EX-101.PRE 10348
8 EXTRACTED XBRL INSTANCE DOCUMENT arch20240109_8k_htm.xml XML 2322
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 24532423
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)